Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13156493 | 0.77 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL16878359 | 0.71 | — | — | |
| Phthalazine SCHEMBL15264828 | 0.71 | CYP2A6 (0.47) | ALDH1A1 | |
| Phthalazine SCHEMBL5675695 | 0.71 | CYP2A6 (0.47) | ALDH1A1 | |
| SCHEMBL9666642 | 0.69 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL8404447 | 0.69 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL29846477 | 0.67 | CDC25B (0.30) | CDC25B | |
| SCHEMBL30574445 | 0.67 | CDC25B (0.30) | CDC25B | |
| SCHEMBL6278613 | 0.60 | — | — | |
| SCHEMBL18507837 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11786600-B2 | Cliptac composition | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-10-17 | — | — | US | claimed |
| US-20190275161-A1 | CLIPTAC COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-09-12 | — | — | US | claimed |
| WO-2017212329-A1 | CLIPTAC COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2017-12-14 | — | — | WO | claimed |
| EP-0145337-B1 | ELECTROCHROMIC DEVICES | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1990-08-08 | — | — | EP | claimed |
| EP-0096723-B1 | BATTERIES FABRICATED WITH ELECTROACTIVE POLYMERS | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1988-08-10 | — | — | EP | claimed |
| US-4613211-A | REVERSE COLOR CHANGING POLYMER FILM AS DISPLAY ELECTRODE | CHEVRON RESEARCH COMPANY (US) | 1986-09-23 | — | — | US | claimed |
| US-4579679-A | Electroactive polymers | CHEVRON RESEARCH COMPANY (US) | 1986-04-01 | — | — | US | claimed |
| EP-0145337-A2 | Electrochromic devices | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1985-06-19 | — | — | EP | claimed |
| US-20240131169-A1 | CLIPTAC COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-04-25 | — | — | US | disclosed |
| US-11786600-B2 | Cliptac composition | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-10-17 | — | — | US | disclosed |
| US-20210038748-A1 | Compositions And Methods For In Vivo Imaging | THE GENERAL HOSPITAL CORPORATION | 2021-02-11 | — | — | US | disclosed |
| EP-3052506-B1 | AZABORININE DERIVATIVES, THEIR SYNTHESIS AND USE IN ORGANIC ELECTRONIC DEVICES | FLEXENABLE LTD (GB) | 2020-06-03 | — | — | EP | disclosed |
| US-10653805-B2 | Compositions and methods for in vivo imaging | THE GENERAL HOSPITAL CORPORATION (US) | 2020-05-19 | — | — | US | disclosed |
| EP-3622968-A1 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | The General Hospital Corporation (US) | 2020-03-18 | — | — | EP | disclosed |
| EP-0145337-B1 | ELECTROCHROMIC DEVICES | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1990-08-08 | — | — | EP | disclosed |
| US-4613211-A | REVERSE COLOR CHANGING POLYMER FILM AS DISPLAY ELECTRODE | CHEVRON RESEARCH COMPANY (US) | 1986-09-23 | — | — | US | disclosed |
| US-4579679-A | Electroactive polymers | CHEVRON RESEARCH COMPANY (US) | 1986-04-01 | — | — | US | disclosed |
| EP-0145337-A2 | Electrochromic devices | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1985-06-19 | — | — | EP | disclosed |
| US-4519937-A | DOPED UNITS OF A FUSED NITROGEN-CONTAINING UNSATURATED HETEROCYCLIC RING | CHEVRON RESEARCH COMPANY (US) | 1985-05-28 | — | — | US | disclosed |
| US-4519938-A | TRACTABLE, DOPED HETEROCYCLIC RINGS | CHEVRON RESEARCH COMPANY (US) | 1985-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210038748-A1 | Compositions And Methods For In Vivo Imaging | PARP1, PARP11, PARP2 | ALDH1A1 3017/4885CDC25B 3798/4885 |
| US-11786600-B2 | Cliptac composition | UBE3C, CBLC, STUB1 | ALDH1A1 3352/4885CDC25B 2648/4885 |
| US-20190275161-A1 | CLIPTAC COMPOSITION | UBE3C, CBLC, STUB1 | ALDH1A1 3352/4885CDC25B 2648/4885 |
| US-20240131169-A1 | CLIPTAC COMPOSITION | UBE3C, CBLC, STUB1 | ALDH1A1 3352/4885CDC25B 2648/4885 |
| US-10653805-B2 | Compositions and methods for in vivo imaging | PARP1, PARP11, PARP2 | ALDH1A1 3017/4885CDC25B 3798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.